pralsetinib (Gavreto) Report issue

Small molecule Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Accelerated Approval FDA Priority Review FDA
Back

Drug Pricing Summary

VA Big4

$112.4422 - $120.0363

VA FSS

$154.7837

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
pralsetinib 100 mg (CAPSULE) $112.4422 VA Big4
  • GAVRETO (60)
    		•  Blueprint Medicines, Inc.
    pralsetinib 100 mg (CAPSULE) $120.0363 VA Big4
  • GAVRETO (90)
    		•  Blueprint Medicines, Inc.
    pralsetinib 100 mg (CAPSULE) $154.7837 VA FSS
  • GAVRETO (60)
    		•  Blueprint Medicines, Inc.
  • GAVRETO (90)
    		•  Blueprint Medicines, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue